Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Poewe

Showing results (291-300 of 602) with videos related to

Pageof 61
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 10, 2004
Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type ABernhard Voller, Ekaterina Moraru, Eduard Auff, et al.
Journal of Neurology|March 25, 2014
Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literatureWolfgang Nachbauer, Michael Nocker, Elfriede Karner, et al.
Nature Reviews. Disease Primers|March 24, 2017
Parkinson diseaseWerner Poewe, Klaus Seppi, Caroline M Tanner, et al.
Parkinsonism & Related Disorders|March 13, 2017
Ocular and visual disorders in Parkinson's disease: Common but frequently overlookedMerel S Ekker, Sabine Janssen, Klaus Seppi, et al.
Annals of Neurology|June 29, 2010
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD studyFabrizio Stocchi, Olivier Rascol, Karl Kieburtz, et al.
CNS Neuroscience & Therapeutics|July 27, 2010
A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's diseaseJoaquim J Ferreira, Olivier Rascol, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2012
Validation of the Innsbruck REM sleep behavior disorder inventoryBirgit Frauscher, Laura Ehrmann, Laura Zamarian, et al.
Drug Safety|December 22, 2007
Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extensionWolfgang Oertel, Werner Poewe, Erik Wolters, et al.
BMC Neurology|March 14, 2020
Symptomatic hemiparkinsonism due to extensive middle and posterior fossa arachnoid cyst: case reportBernadette Wimmer, Stephanie Mangesius, Klaus Seppi, et al.
Movement Disorders Clinical Practice|April 27, 2026
Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical PracticeFrank Jagusch, Elena Redl, Christoph Theyer, et al.
Pageof 61

Showing results (291-300 of 602) with videos related to

Sort By:
Pageof 61
Movement Disorders : Official Journal of the Movement Disorder Society|August 10, 2004
Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type ABernhard Voller, Ekaterina Moraru, Eduard Auff, et al.
Journal of Neurology|March 25, 2014
Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literatureWolfgang Nachbauer, Michael Nocker, Elfriede Karner, et al.
Nature Reviews. Disease Primers|March 24, 2017
Parkinson diseaseWerner Poewe, Klaus Seppi, Caroline M Tanner, et al.
Parkinsonism & Related Disorders|March 13, 2017
Ocular and visual disorders in Parkinson's disease: Common but frequently overlookedMerel S Ekker, Sabine Janssen, Klaus Seppi, et al.
Annals of Neurology|June 29, 2010
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD studyFabrizio Stocchi, Olivier Rascol, Karl Kieburtz, et al.
CNS Neuroscience & Therapeutics|July 27, 2010
A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's diseaseJoaquim J Ferreira, Olivier Rascol, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2012
Validation of the Innsbruck REM sleep behavior disorder inventoryBirgit Frauscher, Laura Ehrmann, Laura Zamarian, et al.
Drug Safety|December 22, 2007
Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extensionWolfgang Oertel, Werner Poewe, Erik Wolters, et al.
BMC Neurology|March 14, 2020
Symptomatic hemiparkinsonism due to extensive middle and posterior fossa arachnoid cyst: case reportBernadette Wimmer, Stephanie Mangesius, Klaus Seppi, et al.
Movement Disorders Clinical Practice|April 27, 2026
Cardiac MIBG Scintigraphy in Neurodegenerative Parkinsonism: Limitations in Clinical PracticeFrank Jagusch, Elena Redl, Christoph Theyer, et al.
Pageof 61